Fig. 6: MYH9 is an independent risk factor in patients with NSCLC. | Cell Death Discovery

Fig. 6: MYH9 is an independent risk factor in patients with NSCLC.

From: MYH9 is crucial for stem cell-like properties in non-small cell lung cancer by activating mTOR signaling

Fig. 6: MYH9 is an independent risk factor in patients with NSCLC.The alternative text for this image may have been generated using AI.

A Expression of MYH9 in NSCLC and paracancerous tissues (scale bar, 100 μm). B IHC divided the expression of MYH9 in lung cancer into four grades: negative (–), weakly positive (+), positive (++), and strongly positive (+++) (scale bar, 100 μm). C Kaplan-Meier survival curve of overall survival in patients with NSCLC (**p < 0.01; Log-rank test). D, E Kaplan-Meier survival curve and univariate analysis were used to study the correlation between MYH9 expression in the cell membrane, cytoplasm, nucleus, and survival prognosis in patients with NSCLC (*p < 0.05and **p < 0.01; Log-rank test).

Back to article page